Skip to main content

Assessment of Iron Stores

CBE ID
0252
Endorsed
Endorsement Status
1.1 New or Maintenance
E&M Cycle
Is Under Review
No
1.3 Measure Description

Percentage of all adult (>=18 years old) hemodialysis or peritoneal dialysis patients prescribed an ESA at any time during the study period or who have a Hb <11.0 g/dL in at least one month of the study period for whom serum ferritin concentration AND either percent transferrin saturation or reticulocyte Hb content (CHr) are measured at least once in a three-month period for in-center hemodialysis patients, peritoneal dialysis patients, and home hemodialysis patients.

        • 1.14 Numerator

          Number of dialysis patients in the denominator for whom serum ferritin concentration AND either percent transferrin saturation or reticulocyte Hb content (CHr) are measured at least once in a three-month period for in-center hemodialysis patients, peritoneal dialysis patients, and home hemodialysis patients.

        • 1.15 Denominator

          All adult (>=18 years old) hemodialysis or peritoneal dialysis patients prescribed an ESA at any time during the study period or who have a Hb <11.0 g/dL in at least one month of the study period. The study period consists of 3 consecutive months for in-center hemodialysis patients, peritoneal dialysis patients and home hemodialysis. The hemoglobin value reported for the end of each study month (end-of-month Hb) is used for this calculation.

        • Exclusions

          Acute HD, transient dialysis patients (seen at the specific center for less than 30 days), and kidney transplant patients are excluded from the calculation this CPM.

        • Most Recent Endorsement Activity
          Measure Retired and Endorsement Removed Renal Consensus Standards Endorsement Maintenance 2011
          Initial Endorsement
          Last Updated
          Removal Date